597528-07-9Relevant articles and documents
HEADGROUP LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
-
Paragraph 00422, (2021/04/01)
The application relates to lipids of Formula (A-1) and compositions involving the same. Lipid nanoparticles (e.g., empty LNPs or loaded LNPs) include such a lipid as well as additional lipids such as phospholipids, structural lipids, and PEG lipids. Lipid nanoparticles (e.g., empty LNPs or loaded LNPs) further including therapeutic and/ or prophylactics such as RNA are useful in the delivery of therapeutic and/or prophylactics to mammalian cells or organs to, for example, regulate polypeptide, protein, or gene expression.
Syntheses, addition-eliminations, and addition-displacements of 5-(bromomethylene)hydantoins
Mathur, Naresh C.,Wong, Sau K.,Shechter, Harold
, p. 5141 - 5144 (2007/10/03)
5-(Bromomethylene)hydantoins, prepared from bromopyruvic acid and ureas in the presence of BF3, react with various nitrogen, phosphorus, sulfur, and carbon nucleophiles by addition-elimination to give the corresponding 5-(substituted-methylene)hydantoins. The 5-(bromomethylene)hydantoins also undergo acid-catalyzed reactions with nucleophiles by addition-displacement and addition-elimination processes.